CompletedNot Applicable

High Velocity Nasal Insufflation Versus Continuous Positive Airway Pressure in COVID 19 Pneumonic Patients

Egypt108 participantsStarted 2022-01-01

Plain-language summary

compare the efficacy of High-Velocity Nasal Insufflation (HVNI) versus Continuous Positive Airway Pressure (CPAP) in managing COVID 19 pneumonic patients with acute type 1 respiratory failure

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged above 18 years with COVID 19 pneumonia with acute type 1 respiratory failure were included. Exclusion Criteria: * patients with hypercapnic respiratory failure. * patients with a disturbed level of consciousness and/or a high risk of aspiration * individuals with hypotension * patients requiring invasive mechanical ventilation.

What they're measuring

Correction of hypoxia in COVID 19 Pneumonic Patients with Acute Type 1 Respiratory Failure

Timeframe: 6 months

Trial details

NCT IDNCT07213518

SponsorMansoura University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-07-01

View on ClinicalTrials.gov More COVID-19 Pneumonia trials